HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

adaptaquin

a low‐molecular weight 8‐hydroxyquinoline inhibitor of hypoxia‐inducible factor prolyl‐4‐hydroxylases (HIF-PHDs)
Also Known As:
7-((4-chlorophenyl)-((3-hydroxypyridin-2-yl)amino)methyl)quinolin-8-ol
Networked: 6 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Boles, Nathan C: 1 article (01/2021)
2. Brown, Jennifer L: 1 article (01/2021)
3. Coutts, David J C: 1 article (01/2021)
4. Curtin, Jessica J: 1 article (01/2021)
5. David, Brian T: 1 article (01/2021)
6. Hill, Caitlin E: 1 article (01/2021)
7. Aimé, Pascaline: 1 article (01/2020)
8. Burke, Robert E: 1 article (01/2020)
9. Chen, Yingxin: 1 article (01/2020)
10. Greene, Lloyd A: 1 article (01/2020)

Related Diseases

1. Hemorrhagic Stroke
2. Hypoxia (Hypoxemia)
3. Ischemia
4. Brain Injuries (Brain Injury)
5. Parkinson Disease (Parkinson's Disease)

Related Drugs and Biologics

1. Prolyl-Hydroxylase Inhibitors
2. Deferoxamine (Desferal)
3. Hypoxia-Inducible Factor-Proline Dioxygenases
4. Caspase 3 (Caspase-3)
5. Apoptosis Inducing Factor
6. Glutamic Acid (Glutamate)
7. Reactive Oxygen Species (Oxygen Radicals)
8. Adenosine Triphosphate (ATP)